Literature DB >> 28319287

Iatrogenic thyrotoxicosis and the role of therapeutic plasma exchange.

Kabeer K Shah1,2, Michael M Mbughuni1,2, Edwin A Burgstaler1, Darci R Block1, Jeffrey L Winters1.   

Abstract

Thyroid storm or severe thyrotoxicosis results from extreme thyroid hormone elevation. Therapy includes medical management to prevent hormone production, release, recycling, and peripheral conversion while stabilizing adrenergic tone. Thyroid dysfunction is the usual cause but it can be due to excessive thyroid hormone ingestion. Therapeutic plasma exchange (TPE) has been used to rapidly remove protein-bound thyroid hormone. American Society for Apheresis guidelines make a weak recommendation to perform TPE in selected patients in the treatment of thyrotoxicosis based on low quality evidence. We present a case of excessive thyroid replacement hormone ingestion treated by TPE. The patient presented with the clinical picture of thyroid storm, including cardiovascular compromise and massively elevated total and free T3 (525 ng/dL, nl 80-200 ng/dL and 28 pg/mL, nl 2.0-3.5 11 pg/mL), which failed medical therapy. A single, one plasma volume TPE was performed. Both total and free T3 demonstrated substantial declines immediately after TPE with the patient's mental status returning to near-normal. Thyroid hormone extraction efficiency and collection efficacy were calculated as 37.1% and 40.8%, respectively. Prior to discharge on day 6, the patient's compounding pharmacy indicated that a "bad batch" of bovine thyroid gland derived replacement hormone had been produced. TPE appears to be effective in removing protein bound thyroid hormone in extreme iatrogenic thyrotoxicosis.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  apheresis; plasma exchange; plasmapheresis; thyroid storm; thyrotoxicosis

Mesh:

Substances:

Year:  2017        PMID: 28319287     DOI: 10.1002/jca.21536

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  6 in total

1.  THERAPEUTIC PLASMA EXCHANGE AS A BRIDGE TO TOTAL THYROIDECTOMY IN PATIENTS WITH SEVERE THYROTOXICOSIS.

Authors:  Kelsey Tieken; Ameena Madan Paramasivan; Whitney Goldner; Ana Yuil-Valdes; Abbey L Fingeret
Journal:  AACE Clin Case Rep       Date:  2020-09-26

2.  Thyrotoxicosis due to 1000-fold error in compounded liothyronine: A case elucidated by mass spectrometry.

Authors:  Wajid Khan; Grace Van Der Gugten; Daniel T Holmes
Journal:  Clin Mass Spectrom       Date:  2018-11-30

3.  Letter to the Editor: Clinically Significant Hyperthyroidism and Hypothyroidism Following Exposure to Compounded Thyroid Products.

Authors:  Jenny Kim; Karen Konkel; Ida-Lina Diak; Shannon Glueck; Lynda McCulley
Journal:  Thyroid       Date:  2020-09-18       Impact factor: 6.568

4.  Graves' Disease Thyrotoxicosis and Propylthiouracil Related Agranulocytosis Successfully Treated with Therapeutic Plasma Exchange and G-CSF Followed by Total Thyroidectomy.

Authors:  Anna Candoni; Federico De Marchi; Fabio Vescini; Sara Mauro; Cristina Rinaldi; Marco Piemonte; Nicholas Rabassi; Maria Vittoria Dubbini; Renato Fanin
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-10-16       Impact factor: 2.576

5.  Successful Plasma Exchange in a Pregnant Patient with Guillain-Barré Syndrome and Thyrotoxicosis.

Authors:  Hülya E Toydemir; Vildan Yayla; Metin Mercan; Hacı Ali Erdoğan; İbrahim Acır; Mehmet Hurşitoğlu; Meral Mert; Bahar Özdemir; Yasemin Tekdöş Şeker; Deniz Özel Bilgi; Gülsüm O Hergünsel; Zeynep Topkarcı
Journal:  Ann Indian Acad Neurol       Date:  2022-01-13       Impact factor: 1.714

Review 6.  Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.

Authors:  C James Watson; James D Whitledge; Alicia M Siani; Michele M Burns
Journal:  J Med Toxicol       Date:  2020-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.